Golimumab: all 71 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs PlaceboNot yet recruitingNCT07683026Phase 2
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
• Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
• Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP StudyTerminatedNCT05960578Phase 2Results posted
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisCompletedNCT05071664Phase 2Results posted
• GOLimumab and Methotrexate Versus Methotrexate in Very Early PsACompletedNCT04108468Phase 3Results posted
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03596645Phase 3Results posted
• Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut InflammationCompletedNCT03270501Phase 3Results posted
• Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)CompletedNCT03253796Phase 4Results posted
• Study of the Golimumab Exposure-Response Relationship Using Serum Trough LevelsCompletedNCT03124121Phase 4Results posted
• A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 DiabetesCompletedNCT02846545Phase 2Results posted
• Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).CompletedNCT02318667Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate TherapyCompletedNCT02277444Phase 3Results posted
• A Study of Golimumab in Participants With Active Ankylosing SpondylitisCompletedNCT02186873Phase 3Results posted
• A Study of Golimumab in Participants With Active Psoriatic ArthritisCompletedNCT02181673Phase 3Results posted
• Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)CompletedNCT02092285Phase 4Results posted
• Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis PatientsCompletedNCT02065713Phase 3Results posted
• A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)TerminatedNCT01962974Phase 3Results posted
• A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.CompletedNCT01863771Phase 3Results posted
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4Results posted
• A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisCompletedNCT01715896Phase 2Results posted
• The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)CompletedNCT01668004Phase 4Results posted
• Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)CompletedNCT01453725Phase 3Results posted
• Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing SpondylitisCompletedNCT01248793Phase 3Results posted
• Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01248780Phase 3Results posted
• A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)TerminatedNCT01230827Phase 3Results posted
• Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
• Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
• An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCompletedNCT00973479Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With SarcoidosisCompletedNCT00955279Phase 2Results posted
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative ColitisTerminatedNCT00488774Phase 2/3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00488631Phase 3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00487539Phase 2/3Results posted
• A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00361335Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)CompletedNCT00299546Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic ArthritisCompletedNCT00265096Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing SpondylitisCompletedNCT00265083Phase 3Results posted
• An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00264550Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naiveCompletedNCT00264537Phase 3Results posted
• A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent AsthmaCompletedNCT00207740Phase 2Results posted
• An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid ArthritisCompletedNCT00207714Phase 2Results posted
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05242484Phase 2
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT05242471Phase 2
• REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)Status unknownNCT05164198Phase 4
• Anti-TNFα to Delay or Prevent Progression to Stage 3 T1DWithdrawnNCT04729296Phase 2
• Golimumab for the Treatment of Refractory Behcet's UveitisTerminatedNCT04218565Phase 2
• The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive DepressionStatus unknownNCT04156425Not applicable
• Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy SubjectsCompletedNCT04152759Phase 1
• Optimization of Golimumab Treatment in Ulcerative ColitisStatus unknownNCT03669029Phase 4
• Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1DCompletedNCT03632759Early Phase 1
• A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 DiabetesCompletedNCT03298542Phase 1
• Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose OptimizationCompletedNCT03182166Phase 2
• Thermography in Assessing Treatment Response to Golimumab in Psoriatic ArthritisTerminatedNCT02841176Not applicable
• Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in ColitisStatus unknownNCT02687724Phase 4
• Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic RemissionStatus unknownNCT02412085Phase 4
• Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With GolimumabStatus unknownNCT02186886Phase 4
• A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT01988961Phase 2
• A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT01900574Phase 1
• Initial Treatment With Golimumab in Early PsACompletedNCT01871649Phase 3
• Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week TrialCompletedNCT01718951Phase 4
• Intratympanic Injection for Autoimmune Inner Ear DiseaseTerminatedNCT01526174Phase 1/2
• Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteriaCompletedNCT01426815Phase 3
• A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)CompletedNCT01362153Phase 1
• SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.CompletedNCT01295151Phase 4
• A Study of the Pharmacokinetics of Golimumab in Chinese Male SubjectsCompletedNCT01288157Phase 1
• Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)CompletedNCT01212653Phase 4
• A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)CompletedNCT00771251Phase 3
• A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00727987Phase 3
• A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent AsthmaWithdrawnNCT00675649Phase 2

← Golimumab overview